Search all medical codes

Injection, panitumumab, 10 mg

HCPCS code

Name of the Procedure:

Injection of Panitumumab (Medical term: J9303)


Panitumumab injection is a treatment where a specialist administers a medication directly into a vein. This drug helps to target and block specific proteins that are involved in the growth of cancer cells.


Panitumumab is primarily used in the treatment of colorectal cancer. It works by slowing down or stopping the growth of cancer cells. The goal is to control the spread of cancer and improve survival rates.


This treatment is appropriate for patients diagnosed with colorectal cancer, particularly when the cancer has certain genetic markers (e.g., KRAS wild type). It's often used when other forms of chemotherapy have not been effective.


  • Patients may be advised to fast for a few hours before the procedure.
  • Important medications should still be taken unless otherwise directed.
  • Blood tests or imaging may be required ahead of time to ensure suitability and optimize dosing.

Procedure Description

  1. Patient Preparation: The patient is seated comfortably, often in a reclining chair.
  2. IV Placement: A nurse or technician inserts an intravenous (IV) line into a vein in the arm.
  3. Injection: Panitumumab is administered slowly through the IV over a set period.
  4. Monitoring: The patient is observed for any immediate reactions during and after the injection.

Tools involve:

  • Sterile needles and IV lines
  • The Panitumumab solution
  • IV infusion pump (if needed)

The procedure usually does not require anesthesia or sedation.


The entire procedure can take between 30 minutes to 2 hours based on the dosage and patient response.


This procedure is typically performed in an outpatient clinic or hospital setting, often in a specialized infusion center.


  • Oncologist
  • Registered Nurse (RN) or Licensed Practical Nurse (LPN)
  • Medical Technician (if applicable)

Risks and Complications

Common risks:

  • Injection site reactions (redness, swelling, pain)
  • Nausea or vomiting
  • Fatigue

Rare risks:

  • Severe allergic reactions
  • Infections
  • Skin issues like rashes or dryness


  • Potential reduction in tumor size
  • Slowing of cancer progression
  • Symptom relief and improved quality of life

Benefits may be realized within weeks to a few months, depending on individual response.


  • Patients can usually go home shortly after the procedure.
  • Patients may need to rest and avoid strenuous activities for the remainder of the day.
  • Regular follow-up appointments to monitor progress and manage side effects.


  • Other chemotherapy drugs
  • Radiation therapy
  • Surgical options
  • Targeted therapies or immunotherapies

Each alternative has its own set of benefits and risks, which should be discussed with an oncologist.

Patient Experience

During the procedure, patients may feel a slight prick from the IV and discomfort at the injection site. They might also experience mild side effects like fatigue or nausea shortly after the procedure, but pain management strategies and supportive care are available to enhance comfort.

Medical Policies and Guidelines for Injection, panitumumab, 10 mg

Related policies from health plans

Vectibix (panitumumab)

Similar Codes

Contact us to learn more

Choose your own adventure


Send us a message or questions and we can share more details.


Setup a calendar meeting with us; find a time now.